NEE
52
-2
AES
55
-3
GE
72
5
CMG
54
4
VRSN
42
-2
EMN
62
-3
VLO
50
-5
NI
63
-4
BK
74
-5
MTCH
57
-2
GOOGL
59
9
AMG
75
-7
DVA
52
-2
MAC
68
-2
FTI
82
-2
KR
32
2
UHS
60
-3
NTRS
64
-3
ETR
52
-2
DOW
43
-5
NEE
52
-2
AES
55
-3
GE
72
5
CMG
54
4
VRSN
42
-2
EMN
62
-3
VLO
50
-5
NI
63
-4
BK
74
-5
MTCH
57
-2
GOOGL
59
9
AMG
75
-7
DVA
52
-2
MAC
68
-2
FTI
82
-2
KR
32
2
UHS
60
-3
NTRS
64
-3
ETR
52
-2
DOW
43
-5
Financhill
Back

Allied Properties Real Estate Investment Trust Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
25

APYRF
Allied Properties Real Estate Investment Trust

Last Price:
$9.55
Seasonality Move:
1.27%
Sell
46

CRSP
CRISPR Therapeutics AG

Last Price:
$56.64
Seasonality Move:
16.15%
Sell
25
Allied Properties Real Estate Investment Trust (APYRF) is a Sell

Is Allied Properties Real Estate Investment Trust a Buy, Sell or Hold?

  • The current Allied Properties Real Estate Investment Trust [APYRF] share price is $9.67. The Score for APYRF is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • APYRF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $56.68. The Score for CRSP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APYRF Stock Price Chart

What is Allied Properties Real Estate Investment Trust's stock price today?

  • The Allied Properties Real Estate Investment Trust share price today is $9.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APYRF is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $56.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight selling pressure.

APYRF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 43.28 Sell
Chaikin Money Flow: 58037 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.19 - 9.85) Buy
Bollinger Bands (100): (10.41 - 14.55) Sell

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 50.79 Buy
Chaikin Money Flow: -310612 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.51 - 56.73) Buy
Bollinger Bands (100): (52.75 - 65.77) Sell

APYRF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.39 Buy
20-day SMA: 9.38 Buy
50-day SMA: 11.21 Sell
200-day SMA: 12.09 Sell
8-day EMA: 9.45 Buy
20-day EMA: 9.66 Buy
50-day EMA: 10.79 Sell
200-day EMA: 12.11 Sell

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.23 Sell
20-day SMA: 54.24 Buy
50-day SMA: 60.61 Sell
200-day SMA: 50.79 Buy
8-day EMA: 56.62 Buy
20-day EMA: 55.98 Buy
50-day EMA: 56.55 Buy
200-day EMA: 36.64 Buy

Allied Properties Real Estate Investment Trust Earnings Growth & APYRF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

Allied Properties Real Estate Investment Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):